Clinical development success rates for investigational drugs

被引：1622
|
作者：
Hay, Michael [1 ]
Thomas, David W. [2 ]
Craighead, John L. [3 ]
Economides, Celia [2 ]
Rosenthal, Jesse [1 ]
机构：
[1] Sagient Res Syst, BioMedTracker, San Diego, CA 92122 USA
[2] BIO, Washington, DC USA
[3] Biotech Strategy & Analyt, Rockville, MD USA
来源：
NATURE BIOTECHNOLOGY | 2014年 / 32卷 / 01期
关键词：
PRODUCTIVITY; TRENDS; SCALE; RISKS; SCOPE;
D O I：
10.1038/nbt.2786
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
The most comprehensive survey of clinical success rates across the drug industry to date shows productivity may be even lower than previous estimates.
引用
收藏
页码：40 / 51
页数：12
相关论文
共 50 条
  • [1] Clinical development success rates for investigational drugs
    Michael Hay
    David W Thomas
    John L Craighead
    Celia Economides
    Jesse Rosenthal
    Nature Biotechnology, 2014, 32 : 40 - 51
  • [2] Clinical Approval Success Rates for Investigational Cancer Drugs
    DiMasi, J. A.
    Reichert, J. M.
    Feldman, L.
    Malins, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (03) : 329 - 335
  • [3] Risks in new drug development: Approval success rates for investigational drugs
    DiMasi, JA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (05) : 297 - 307
  • [4] Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs
    DiMasi, J. A.
    Feldman, L.
    Seckler, A.
    Wilson, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (03) : 272 - 277
  • [5] Clinical Development Success Rates for Innovative Drugs in China
    Wang, Qing-Hua
    Lin, Jie
    Peng, Nan
    Wang, Quan-Ming
    Li, Melissa
    Liu, Gordon G.
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2022, 18 (06) : 1137 - 1150
  • [6] Clinical Trial Success Rates of Investigational Antileukemic Drugs Presented at the American Society of Hematology (ASH) Meetings
    Miranda, Marisol
    Medeiros, Thalyta
    Lopez, Claudia Guillen
    Mamouni, Kenza
    Cortes, Jorge E.
    BLOOD, 2022, 140 : 10843 - 10844
  • [7] Investigational drugs in early clinical development for portal hypertension
    Rodrigues, Susana G.
    Mendoza, Yuly P.
    Bosch, Jaime
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (08) : 825 - 842
  • [8] BIOPHARMACEUTICALS AND CONVENTIONAL DRUGS - CLINICAL SUCCESS RATES
    BIENZTADMOR, B
    DICERBO, PA
    TADMOR, G
    LASAGNA, L
    BIO-TECHNOLOGY, 1992, 10 (05): : 521 - 525
  • [9] Investigational cancer drugs targeting cell metabolism in clinical development
    Sborov, Douglas W.
    Haverkos, Bradley M.
    Harris, Pamela J.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (01) : 79 - 94
  • [10] Investigational antiarrhythmic agents: promising drugs in early clinical development
    Heijman, Jordi
    Ghezelbash, Shokoufeh
    Dobrev, Dobromir
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (08) : 897 - 907
12345